Skip to content

Improving Prognostic Confidence in Neurodegenerative Diseases Causing Dementia Using Peripheral Biomarkers and Integrative Modeling

Parkinson Disease | Alzheimer Disease | Progressive Supranuclear Palsy | Mild Cognitive Impairment |...

To develop a model to predict disease progression in a large cohort of patients across a variety of neurodegenerative diseases, including Mild Cognitive Impairment (MCI) and dementia due to any neurodegenerative disease, including Alzheimer's Disease (AD), Lewy Body Disease (LBD), Vascular Disease (VaD) and Frontotemporal lobar degeneration (FTLD).

null

Participation Requirements

  • Sex:

    ALL
  • Eligible Ages:

    40 and up

Participation Criteria

Inclusion Criteria:

* Referring diagnosis of MCI or early dementia
* Age 40-95
* Study partner who has some weekly contact with patient. Some of the neuropsychological assessment require collateral from close contacts to assess cognition and functioning. Since neurodegenerative diseases can be associated with reduced cognition, including reduced awareness of one's own impairments, participants will be assessed for their capacity to consent at all study visits.
* Must, in the opinion of the site investigator, be able to complete most study procedures.

Exclusion Criteria:

* Participants who are not able to complete the majority of assessments in the opinion of the PI are excluded from the study. Exclusion criteria are evaluated at the site investigator's discretion; if the site investigator believes that the participant's symptoms are due to causes other than neurodegeneration, despite the presence of an exclusionary condition, the investigator may overrule the exclusion.

Study Location

Centre for Addiction and Mental Health
Centre for Addiction and Mental Health
Toronto, Ontario
Canada

Contact Study Team

Backup Contact

Sanjeev Kumar, MD

Backup Contact

Tarek Rajji, MD

Primary Contact

Jake McCallum

[email protected]
Toronto Western Hospital, University Health Network
Toronto Western Hospital, University Health Network
Toronto, Ontario
Canada

Contact Study Team

Primary Contact

Claudia Clementi

[email protected]
416-603-5914
Backup Contact

Maria C Tartaglia, MD

Baycrest
Baycrest
North York, Ontario
Canada

Contact Study Team

Primary Contact

Aymin Mumtaz

[email protected]
416-785-2500
Backup Contact

Morris Freedman, MD

Sunnybrook Health Sciences Centre
Sunnybrook Health Sciences Centre
Toronto, Ontario
Canada

Contact Study Team

Backup Contact

Sandra E Black, MD

Primary Contact

Ljubica Zotovic

[email protected]
416-480-6100
Study Sponsored By
University Health Network, Toronto
Participants Required
More Information
Study ID: NCT06529744